Literature DB >> 20304553

Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction.

Stefano Leone1, Tommaso Cornetta, Emiliano Basso, Renata Cozzi.   

Abstract

Resveratrol, a stilbene found in grapes and wine, is one of the most interesting natural compound due to its role exerted in cancer prevention and therapy. In particular, resveratrol is able to delay cell cycle progression and to induce apoptotic death in several cell lines. Here we report that resveratrol treatment of human glioblastoma cells induces a delay in cell cycle progression during S phase associated with an increase in histone H2AX phosphorylation. Furthermore, with an in vitro assay of topoisomerase IIalpha catalytic activity we show that resveratrol is able to inhibit the ability of recombinant human TOPO IIalpha to decatenate kDNA, so that it could be considered a TOPO II poison. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304553     DOI: 10.1016/j.canlet.2010.02.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor.

Authors:  A Arivazhagan; Durairaj Mohan Kumar; Vinay Sagar; Irene Rosita Pia Patric; S Sridevi; Balaram Thota; Mallavarapu R Srividya; K Prasanna; K Thennarasu; Neelima Mondal; A S Hegde; B A Chandramouli; V Santosh; M R S Rao; P Kondaiah; K Somasundaram
Journal:  J Neurooncol       Date:  2011-11-19       Impact factor: 4.130

2.  Encapsulation of micronutrients resveratrol, genistein, and curcumin by folic acid-PAMAM nanoparticles.

Authors:  P Chanphai; H A Tajmir-Riahi
Journal:  Mol Cell Biochem       Date:  2018-05-21       Impact factor: 3.396

Review 3.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

4.  Resveratrol: A novel type of topoisomerase II inhibitor.

Authors:  Joyce H Lee; Timothy J Wendorff; James M Berger
Journal:  J Biol Chem       Date:  2017-10-26       Impact factor: 5.157

5.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

6.  Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells.

Authors:  Praveen Rajendran; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Clin Epigenetics       Date:  2011-10-26       Impact factor: 6.551

Review 7.  Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives.

Authors:  Beatrice Mercorelli; David Lembo; Giorgio Palù; Arianna Loregian
Journal:  Pharmacol Ther       Date:  2011-04-28       Impact factor: 12.310

8.  Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol.

Authors:  Artur Zajkowicz; Małgorzata Krześniak; Iwona Matuszczyk; Magdalena Głowala-Kosińska; Dorota Butkiewicz; Marek Rusin
Journal:  Mol Biol Rep       Date:  2013-05-11       Impact factor: 2.316

9.  ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.

Authors:  Hani Lee; Yonghwan Kim; Ji Hye Jeong; Jae-Ha Ryu; Woo-Young Kim
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

10.  Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation.

Authors:  Megha Jhanji; Chintada Nageswara Rao; Mathew Sajish
Journal:  Geroscience       Date:  2020-11-27       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.